CareDx, Inc. (CDNA): Price and Financial Metrics


CareDx, Inc. (CDNA): $67.97

0.63 (+0.94%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

CDNA POWR Grades


  • Quality is the dimension where CDNA ranks best; there it ranks ahead of 66.65% of US stocks.
  • CDNA's strongest trending metric is Momentum; it's been moving down over the last 47 weeks.
  • CDNA ranks lowest in Momentum; there it ranks in the 16th percentile.

CDNA Stock Summary

  • With a one year PEG ratio of 752.16, CareDx Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 95.89% of US stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.22 for CareDx Inc; that's greater than it is for just 12.36% of US stocks.
  • Revenue growth over the past 12 months for CareDx Inc comes in at 69.28%, a number that bests 90.67% of the US stocks we're tracking.
  • Stocks that are quantitatively similar to CDNA, based on their financial statements, market capitalization, and price volatility, are IDN, RDFN, WK, NCNO, and ESTC.
  • Visit CDNA's SEC page to see the company's official filings. To visit the company's web site, go to www.caredx.com.

CDNA Valuation Summary

  • In comparison to the median Healthcare stock, CDNA's price/sales ratio is 33.92% higher, now standing at 15.2.
  • CDNA's price/sales ratio has moved up 10.9 over the prior 87 months.
  • CDNA's price/sales ratio has moved up 10.9 over the prior 87 months.

Below are key valuation metrics over time for CDNA.

Stock Date P/S P/B P/E EV/EBIT
CDNA 2021-08-31 15.2 8.0 -431.0 -354.3
CDNA 2021-08-30 16.7 8.8 -473.6 -392.4
CDNA 2021-08-27 16.6 8.8 -469.6 -388.8
CDNA 2021-08-26 16.0 8.5 -454.2 -375.1
CDNA 2021-08-25 16.0 8.5 -454.1 -375.0
CDNA 2021-08-24 16.2 8.6 -459.0 -379.3

CDNA Growth Metrics

  • Its 4 year cash and equivalents growth rate is now at 35.71%.
  • Its year over year revenue growth rate is now at 58.62%.
  • Its 2 year net income to common stockholders growth rate is now at 65.59%.
CDNA's revenue has moved up $188,038,000 over the prior 33 months.

The table below shows CDNA's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 253.601 -11.454 -8.947
2021-03-31 221.214 2.856 -13.578
2020-12-31 192.194 33.431 -18.714
2020-09-30 169.371 25.167 -19.976
2020-06-30 149.813 20.565 -18.971
2020-03-31 139.466 0.043 -20.26

CDNA's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • CDNA has a Quality Grade of C, ranking ahead of 66.65% of graded US stocks.
  • CDNA's asset turnover comes in at 0.557 -- ranking 45th of 80 Healthcare stocks.
  • CSU, MGLN, and CYH are the stocks whose asset turnover ratios are most correlated with CDNA.

The table below shows CDNA's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.557 0.680 -0.105
2021-03-31 0.550 0.673 -0.201
2020-12-31 0.628 0.672 -0.382
2020-09-30 0.673 0.664 -0.802
2020-06-30 0.751 0.655 -1.009
2020-03-31 0.936 0.655 -1.478

CDNA Price Target

For more insight on analysts targets of CDNA, see our CDNA price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $107.33 Average Broker Recommendation 1.36 (Strong Buy)

CDNA Stock Price Chart Interactive Chart >

Price chart for CDNA

CDNA Price/Volume Stats

Current price $67.97 52-week high $99.83
Prev. close $67.34 52-week low $30.27
Day low $67.17 Volume 998,500
Day high $68.95 Avg. volume 642,706
50-day MA $77.13 Dividend yield N/A
200-day MA $77.57 Market Cap 3.58B

CareDx, Inc. (CDNA) Company Bio


CareDx, Inc. focuses on the discovery, development, and commercialization of diagnostic surveillance solutions for transplant patients in North America, Europe, the Middle East, Africa, and Latin America. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. CareDx, Inc. was incorporated in 1998 and is based in Brisbane, California.


CDNA Latest News Stream


Event/Time News Detail
Loading, please wait...

CDNA Latest Social Stream


Loading social stream, please wait...

View Full CDNA Social Stream

Latest CDNA News From Around the Web

Below are the latest news stories about CareDx Inc that investors may wish to consider to help them evaluate CDNA as an investment opportunity.

CareDx Names Longtime Patient Advocate Art Torres to Board of Directors

Torres Adds Expertise in Regenerative Medicine and Organ Procurement to the CareDx BoardSOUTH SAN FRANCISCO, Calif., Sept. 15, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced the appointment of patient advocate, political leader, and former state senator Art Torres to its Board

Yahoo | September 15, 2021

Miromatrix Welcomes Dr. John Barry as Vice President of Research and Development

EDEN PRAIRIE, Minn., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced the hiring of Dr. John Barry as Vice President of Research and Development. Dr. Barry will be leading the activities for the development of the Company's transplantable liver and kidney programs including the use of a bio-engineered liver in an

Yahoo | September 9, 2021

10 Reddit YOLO Stocks That Are Losing Ground

In this article, we discuss the 10 Reddit YOLO stocks that are losing ground. If you want to skip our detailed analysis of these stocks, go directly to the 5 Reddit YOLO Stocks That Are Losing Ground. Retail investors have become an important market force in recent months, giving established stock market experts a run […]

Yahoo | September 4, 2021

Is CareDx (CDNA) A Good Stock To Buy Now?

No summary available.

Insider Monkey | September 2, 2021

CareDx to Participate in Upcoming Conferences

SOUTH SAN FRANCISCO, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announced today the Company plans to participate in the 2021 Wells Fargo Healthcare Conference and H.C. Wainwright 23 rd Annual Global Investment Conference.

Intrado Digital Media | September 2, 2021

Read More 'CDNA' Stories Here

CDNA Price Returns

1-mo -7.52%
3-mo -24.69%
6-mo 10.31%
1-year 99.74%
3-year 161.93%
5-year 1,647.30%
YTD -6.18%
2020 235.88%
2019 -14.20%
2018 242.51%
2017 171.85%
2016 -57.81%

Continue Researching CDNA

Want to see what other sources are saying about CareDx Inc's financials and stock price? Try the links below:

CareDx Inc (CDNA) Stock Price | Nasdaq
CareDx Inc (CDNA) Stock Quote, History and News - Yahoo Finance
CareDx Inc (CDNA) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7934 seconds.